We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $32.4B
1-Year Est. Return 58.5%
This Fund
S&P 500
This Quarter Est. Return
+23.19%
1 Year Est. Return
+58.5%
3 Year Est. Return
+155.34%
5 Year Est. Return
+222.91%
10 Year Est. Return
AUM
$32.4B
AUM Growth
+$5.91B
Cap. Flow
+$1.91B
Cap. Flow %
5.91%
Top 10 Hldgs %
17.19%
Holding
1,187
New
164
Increased
545
Reduced
215
Closed
176

Sector Composition

Rank Sector Weight
1 Healthcare 25.1%
2 Technology 24.74%
3 Financials 10.96%
4 Consumer Discretionary 9.79%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
326
ICU Medical
ICUI
$3.94B
$24.1M 0.07%
164,305
EVR icon
327
Evercore
EVR
$10.9B
$24M 0.07%
70,414
+20,331
+41% +$6.96M
SYK icon
328
Stryker
SYK
$103B
$23.7M 0.07%
75,286
-53,092
-41% -$16.7M
PWR icon
329
Quanta Services
PWR
$97.6B
$23.6M 0.07%
32,752
+3,545
+12% +$2.42M
SO icon
330
Southern Company
SO
$101B
$23.5M 0.07%
246,048
+30,377
+14% +$2.86M
LECO icon
331
Lincoln Electric
LECO
$13.8B
$23.5M 0.07%
88,401
+6,096
+7% +$1.6M
PENN icon
332
PENN Entertainment
PENN
$2.33B
$23.4M 0.07%
1,097,415
+533,006
+94% +$9.55M
SKYT
333
DELISTED
SkyWater Technology
SKYT
$23.4M 0.07%
671,911
+3,022
+0.5% +$103K
LUNR icon
334
Intuitive Machines
LUNR
$2.33B
$23.4M 0.07%
1,091,950
+681
+0.1% +$19.1K
GLUE icon
335
Monte Rosa Therapeutics
GLUE
$1.2B
$23.3M 0.07%
962,884
+888,388
+1,193% +$16.8M
SGMT icon
336
Sagimet Biosciences
SGMT
$675M
$23.2M 0.07%
3,000,652
+1,999,709
+200% +$13.6M
CRWV
337
CoreWeave
CRWV
$50.1B
$23.2M 0.07%
+232,685
New +$25.1M
DVA icon
338
DaVita
DVA
$11.7B
$22.9M 0.07%
102,807
-350,172
-77% -$63.6M
CDNS icon
339
Cadence Design Systems
CDNS
$79.3B
$22.6M 0.07%
60,216
+6,901
+13% +$2.42M
KLAC icon
340
KLA
KLAC
$236B
$22.5M 0.07%
74,637
+23,387
+46% +$4.64M
BBIO icon
341
BridgeBio Pharma
BBIO
$14.2B
$22.4M 0.07%
301,312
+300
+0.1% +$21K
NOW icon
342
ServiceNow
NOW
$136B
$22.4M 0.07%
225,934
+185,483
+459% +$18.4M
EMN icon
343
Eastman Chemical
EMN
$7.78B
$22.2M 0.07%
331,620
-328,905
-50% -$24.1M
LFST icon
344
Lifestance Health
LFST
$5.01B
$22.2M 0.07%
2,068,445
+253,224
+14% +$1.96M
PEP icon
345
PepsiCo
PEP
$186B
$22M 0.07%
162,649
-25,135
-13% -$3.76M
MAZE
346
Maze Therapeutics
MAZE
$1.38B
$22M 0.07%
736,216
+85,987
+13% +$2.25M
IBRX icon
347
ImmunityBio
IBRX
$8.57B
$21.9M 0.07%
2,500,189
-947,157
-27% -$7.17M
COO icon
348
Cooper Companies
COO
$10.1B
$21.8M 0.07%
304,126
+4,200
+1% +$275K
BNY
349
Bank of New York Mellon
BNY
$110B
$21.7M 0.07%
149,841
+15,038
+11% +$2.06M
PNC icon
350
PNC Financial Services
PNC
$96.9B
$21.6M 0.07%
87,672
+9,105
+12% +$2.04M

Similar funds

Woodline Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Woodline Partners held 1,187 positions worth $32.4B, up 22% from $26.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $1.91B of net new capital in Q2 2026, opening 164 new positions and adding to 545 existing holdings. Its largest new stake was SpaceX: 508,235 shares worth $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Texas Instruments, an estimated $215M trimmed.

  • Woodline Partners's largest Q2 2026 buy was SpaceX: 508,235 shares worth $86.8M.
  • Woodline Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $261M increase.
  • Woodline Partners's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $215M.
  • Woodline Partners fully exited SSR Mining in Q2 2026, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 17% of its $32.4B portfolio in Q2 2026.
  • Woodline Partners opened 164 new positions and closed 176 in Q2 2026.
  • Woodline Partners's portfolio value rose 22% quarter-over-quarter to $32.4B.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.